Fulgent Genetics CFO withholds 1,168 shares for taxes

For Fulgent Genetics, Inc. (FLGT), CFO and Treasurer Paul Kim reported a Form 4 transaction involving 1,168 shares of common stock on 2026-08-26.

Rhea-AI Filing Summary

For Fulgent Genetics, Inc. (FLGT), CFO and Treasurer Paul Kim reported a Form 4 transaction involving 1,168 shares of common stock on 2026-08-26. The shares were withheld to satisfy tax withholding obligations triggered by the vesting of restricted stock units, not sold in an open-market trade. After this tax-withholding disposition, Kim’s directly held stake is 358,630 shares of common stock.

Insider Trade Summary

Tax Withholding: 1,168 shares

Tax Withholding 1 txn

Insider Kim Paul

Role CFO and Treasurer

Type	Security	Shares	Price	Value
Tax Withholding	Common Stock F1	1,168	$19.81	$23K

Holdings After Transaction: Common Stock — 358,630 shares (Direct)

Footnotes (1)

1. F1. The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024.

Key Figures

Shares withheld for taxes: 1,168 shares of Common Stock Transaction price per share: $19.81 per share Shares owned after transaction: 358,630 shares of Common Stock +1 more

4 metrics

Shares withheld for taxes 1,168 shares of Common Stock Withheld on 2026-08-26 to satisfy tax withholding obligations on RSU vesting

Transaction price per share $19.81 per share Applied to the 1,168 shares withheld for tax obligations

Shares owned after transaction 358,630 shares of Common Stock Direct holdings of Paul Kim following the 2026-08-26 transaction

Transaction date 2026-08-26 Date of tax-withholding disposition of 1,168 shares

Key Terms

restricted stock units, tax withholding obligations, Form 4

3 terms

restricted stock units financial

"upon the vesting of certain restricted stock units granted to the reporting person"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

tax withholding obligations financial

"withheld from the reporting person to satisfy the tax withholding obligations"

Form 4 regulatory

"originally reported on Form 4 filed with the U.S. Securities"

Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did FLGT CFO Paul Kim report on this Form 4?

Paul Kim reported that 1,168 FLGT common shares were disposed of on 2026-08-26 through shares being withheld to cover tax withholding obligations arising from the vesting of previously granted restricted stock units.

Was the FLGT insider transaction an open-market sale?

No. The Form 4 states the 1,168 shares were withheld to satisfy tax withholding obligations upon RSU vesting, coded as a Form 4 F transaction, rather than being sold in an open-market trade.

What price per share is reported for Paul Kim’s FLGT tax-withholding transaction?

The Form 4 reports a transaction price of $19.81 per share for the 1,168 shares of Fulgent Genetics common stock that were withheld to satisfy tax withholding obligations tied to RSU vesting.

How many FLGT shares does Paul Kim hold after this Form 4 transaction?

Following the tax-withholding disposition of 1,168 shares, Paul Kim directly holds 358,630 shares of Fulgent Genetics common stock, as disclosed in the Form 4.

What event triggered the FLGT share withholding for Paul Kim?

The share withholding was triggered by the vesting of restricted stock units granted on February 26, 2024, with the Form 4 noting that the withholding satisfied tax withholding obligations arising from that RSU vesting.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/28/2026 - 06:06 PM EDT Accepted by SEC EDGAR 08/28/2026 - 06:06 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kim Paul

(Last) (First) (Middle)

C/O FULGENT GENETICS, INC.

4399 SANTA ANITA AVENUE

(Street)

EL MONTE CALIFORNIA 91731

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Fulgent Genetics, Inc. [ FLGT ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	CFO and Treasurer

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
08/26/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	08/26/2026		F		1,168(1)	D	$19.81	358,630	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The shares were withheld from the reporting person to satisfy the tax withholding obligations that arose upon the vesting of certain restricted stock units granted to the reporting person on February 26, 2024, which grant was originally reported on Form 4 filed with the U.S. Securities and Exchange Commission on February 28, 2024.

	/s/ Paul Kim	08/28/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)